Establishment of SLC7A11‐knockout mouse and its preliminary investigation in melanoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Establishment of SLC7A11‐knockout mouse and its preliminary investigation in melanoma
Authors
Keywords
-
Journal
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-07
DOI
10.1007/s11626-023-00819-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
- (2023) Gabriele Romano et al. Cancer Immunology Research
- Cancer treatment and survivorship statistics, 2022
- (2022) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma
- (2022) Meng Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization
- (2021) Nian Liu et al. MOLECULAR THERAPY
- A Review of the Molecular Pathways Involved in Resistance to BRAF Inhibitors in Patients with Advanced-Stage Melanoma
- (2020) Yangzi Tian et al. MEDICAL SCIENCE MONITOR
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
- (2020) Pranavi Koppula et al. Protein & Cell
- mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis
- (2019) Chunjia Li et al. CELL DEATH AND DIFFERENTIATION
- Slc7a11 Modulated by POU2F1 Is Involved in Pigmentation in Rabbit
- (2019) Yang Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities
- (2019) Michele Lai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High SLC7A11 expression in normal skin of melanoma patients
- (2019) Ismael Galván et al. Cancer Epidemiology
- Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma
- (2018) Liang Zhang et al. Future Oncology
- RNAi-mediated SLC7A11 knockdown inhibits melanogenesis-related genes expression in rabbit skin fibroblasts
- (2018) Naisu Yang et al. JOURNAL OF GENETICS
- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Advances in Immunotherapy for Melanoma: A Comprehensive Review
- (2017) Carmen Rodríguez-Cerdeira et al. MEDIATORS OF INFLAMMATION
- Genetic favouring of pheomelanin-based pigmentation limits physiological benefits of coloniality in lesser kestrels Falco naumanni
- (2017) Ismael Galván et al. MOLECULAR ECOLOGY
- CXCL9: evidence and contradictions for its role in tumor progression
- (2016) Qiang Ding et al. Cancer Medicine
- Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma
- (2016) Laetitia Douguet et al. OncoImmunology
- Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
- (2015) Ming-zhe Ma et al. CANCER LETTERS
- Abstract 3209: The expression of SLC7A11 transporter in lung and pancreatic cancer tissues at different stages of development
- (2015) Jonathan A. Moreno et al. CANCER RESEARCH
- TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10
- (2015) Ileana S. Mauldin et al. INTERNATIONAL JOURNAL OF CANCER
- The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
- (2015) Tamás Barbai et al. Oncotarget
- Experimental Study on Residual Tumor Angiogenesis after Cryoablation
- (2014) Chun-Hua Ma et al. Asian Pacific Journal of Cancer Prevention
- Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
- (2014) R. M. Drayton et al. CLINICAL CANCER RESEARCH
- MicroRNA-26b Represses Colon Cancer Cell Proliferation by Inhibiting Lymphoid Enhancer Factor 1 Expression
- (2014) Z. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
- (2013) Vikram Pattanayak et al. NATURE BIOTECHNOLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background
- (2012) Devarati Mitra et al. NATURE
- Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
- (2011) Weijie Guo et al. CANCER LETTERS
- MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11
- (2011) Xiao-Xiao Liu et al. FEBS LETTERS
- Regression of established subcutaneous B16-F10 murine melanoma tumors aftergefgene therapy associated with the mitochondrial apoptotic pathway
- (2009) Jose Prados et al. EXPERIMENTAL DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now